12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 11 (10) , 934-941
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy SwineJournal of Vascular and Interventional Radiology, 2016
- Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery DiseaseNew England Journal of Medicine, 2015
- Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular HealingJACC: Cardiovascular Interventions, 2015
- Calcium Burden Assessment and Impact on Drug-Eluting Balloons in Peripheral Arterial DiseaseCardioVascular and Interventional Radiology, 2014
- National trends in lower extremity bypass surgery, endovascular interventions, and major amputationsJournal of Vascular Surgery, 2009
- Patterns of treatment for peripheral arterial disease in the United States: 1996-2005Journal of Vascular Surgery, 2009
- Prevalence and clinical impact of stent fractures after femoropopliteal stentingJACC, 2005
- EuroQol: the current state of playHealth Policy, 1996
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990